Biotechnology

Moderna Faces Challenges, MRNA Stock Continues YTD Decline

Moderna faces challenges with declining sales and pipeline delays, raising concerns for investors as it navigates its 2025 outlook in a shifting market.

Shares Soar as GH Research Unveils Promising Drug Trial

GH Research PLC's stock soared 89% after promising results for GH001, an innovative therapy for treatment-resistant depression. Explore the potential.

Thermo Fisher Posts Strong Q4 Earnings Boosting Stock

Thermo Fisher Scientific's Q4 results show increased earnings and revenue, with strong product launches and a positive outlook for future growth.

Akero (AKRO) Stock Surges on Promising Drug Results

Akero Therapeutics' efruxifermin shows promising results in treating liver cirrhosis, driving stock surges and revealing new investment prospects in biotech.

J&J Achieves Strong Q4 Performance

Johnson & Johnson's Q4 results reveal strong revenue growth, driven by Darzalex sales, and an optimistic outlook for 2025 amidst strategic acquisitions.

Intuitive Surgical Surpasses Q4 Expectations

Intuitive Surgical's Q4 revenue surged 25%, fueled by strong system placements. Analysts express optimism about future growth.

Bird Flu Risk Sparks Pharma Gains

The recent H5N1 bird flu death and rising seasonal flu cases create investment opportunities in pharmaceuticals and healthcare, highlighting pandemic preparedness.

Promising Results for Amgen's MariTide

Amgen's MariTide shows promising weight-loss results but faces competition and side effect challenges.

Merck Eyes Incyte for Possible Acquisition

Merck (MRK) is rumored to be pursuing Incyte (INCY), prompting market volatility.

Evotec Receives Takeover Bid from Halozyme (HALO)

Evotec has received a takeover offer from Halozyme, potentially creating a major player in life sciences. Retail investors should watch for market impacts.

NTRA Stock: Impressive Growth and Rising Profit Margins

Natera's impressive Q3 2024 highlights its strong position in the genetic testing market.

Global Fungal Outbreaks Surge

Fungal outbreaks are increasing globally, impacting health systems and creating new investment opportunities in antifungal research and treatments.

BMY Breaking New Ground in Schizophrenia Treatment

Bristol Myers Squibb's Cobenfy, the first new schizophrenia treatment in over 70 years, offers hope for patients and investment potential for the market.

Viridian Therapeutics: A Biotech Tapping High-Growth Potential

See how Viridian Therapeutics (NASDAQ: VRDN) is innovating thyroid eye disease treatments with advanced therapies and a growing market opportunity.

Billion-Dollar Market Potential for Targeted Cancer Therapies

Radiopharmaceuticals are revolutionizing cancer treatment, attracting billions in investments. Discover the potential and challenges for investors in this emerging market.